Interleukin Genetics - Ownership and Business Overview

Life ScienceCompany

Interleukin Genetics Ownership

Who owns Interleukin Genetics?

Interleukin Genetics is owned by Orig3n. It was acquired on November 22, 2017.

Was Interleukin Genetics formerly PE-backed?

Yes. Interleukin Genetics was formerly owned by 1 private investor.

Interleukin Genetics Business Overview

Where is Interleukin Genetics headquartered?

Interleukin Genetics is headquartered in Waltham, Massachusetts.

What sector is Interleukin Genetics in?

Interleukin Genetics is a life science company.

When was Interleukin Genetics founded?

Interleukin Genetics was founded in 1986.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Interleukin Genetics, Inc.

135 Beaver Street,
Waltham, Massachusetts 2452
United States,
(781) 398-0700
www.ilgenetics.com

Interleukin Genetics, Inc. is a genetics-based personalized health company that develops genetic tests for use in the emerging personalized health market. Our vision is to build a leading personalized health and wellness company.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.